Published in Reprod Toxicol on January 19, 2007
Relation of DNA methylation of 5'-CpG island of ACSL3 to transplacental exposure to airborne polycyclic aromatic hydrocarbons and childhood asthma. PLoS One (2009) 2.38
Environmental epigenetics and asthma: current concepts and call for studies. Am J Respir Crit Care Med (2008) 2.26
Persistent hypomethylation in the promoter of nucleosomal binding protein 1 (Nsbp1) correlates with overexpression of Nsbp1 in mouse uteri neonatally exposed to diethylstilbestrol or genistein. Endocrinology (2008) 1.95
Epigenetic reprogramming and imprinting in origins of disease. Rev Endocr Metab Disord (2007) 1.75
Maternal obesity and developmental programming of metabolic disorders in offspring: evidence from animal models. Exp Diabetes Res (2011) 1.43
Investigating parent of origin effects in studies of type 2 diabetes and obesity. Curr Diabetes Rev (2008) 1.24
Developmental programming and endocrine disruptor effects on reproductive neuroendocrine systems. Front Neuroendocrinol (2008) 1.21
Environmental epigenetics and its implication on disease risk and health outcomes. ILAR J (2012) 1.10
Developmental programming of the metabolic syndrome - critical windows for intervention. World J Diabetes (2011) 1.07
Long-term effects of environmental endocrine disruptors on reproductive physiology and behavior. Front Behav Neurosci (2009) 1.04
Emerging technology in molecular epidemiology: what epidemiologists need to know. Epidemiology (2008) 1.02
Epigenetic changes in fetal hypothalamic energy regulating pathways are associated with maternal undernutrition and twinning. FASEB J (2012) 1.00
Lymphoma and lung cancer in offspring born to pregnant mice dosed with dibenzo[a,l]pyrene: the importance of in utero vs. lactational exposure. Toxicol Appl Pharmacol (2008) 0.96
In utero exposure to di-(2-ethylhexyl) phthalate decreases mineralocorticoid receptor expression in the adult testis. Endocrinology (2009) 0.93
Epigenetic regulation of the expression of genes involved in steroid hormone biosynthesis and action. Steroids (2010) 0.92
Patterns and possible roles of LINE-1 methylation changes in smoke-exposed epithelia. PLoS One (2012) 0.92
Epigenetic and microRNA-mediated regulation in diabetes. Nephrol Dial Transplant (2009) 0.88
Considerations for Using Genetic and Epigenetic Information in Occupational Health Risk Assessment and Standard Setting. J Occup Environ Hyg (2015) 0.86
Transgenerational inheritance of prenatal obesogen exposure. Mol Cell Endocrinol (2014) 0.84
DNA fingerprinting techniques for the analysis of genetic and epigenetic alterations in colorectal cancer. Mutat Res (2010) 0.83
Transgenerational effects of obesogens and the obesity epidemic. Curr Opin Pharmacol (2014) 0.82
DNA/RNA markers for colorectal cancer risk in preserved stool specimens: a pilot study. Tumori (2010) 0.80
Epigenetic regulation of persistent pain. Transl Res (2014) 0.80
Recent progress in the genetics and epigenetics of paraoxonase: why it is relevant to children's environmental health. Curr Opin Pediatr (2015) 0.79
Omics Screening for Pharmaceutical Efficacy and Safety in Clinical Practice. J Pharmacogenomics Pharmacoproteomics (2012) 0.79
Hypermethylation of CpG islands is more prevalent than hypomethylation across the entire genome in breast carcinogenesis. Clin Exp Med (2012) 0.78
DNA methylation screening and analysis. Methods Mol Biol (2012) 0.77
DNA methylation within the I.4 promoter region correlates with CYPl19A1 gene expression in human ex vivo mature omental and subcutaneous adipocytes. BMC Med Genet (2013) 0.75
Genome-wide location and function of DNA binding proteins. Science (2000) 31.25
Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci U S A (1996) 29.54
A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands. Proc Natl Acad Sci U S A (1992) 29.51
Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat Genet (2003) 25.57
Chromosome-wide and promoter-specific analyses identify sites of differential DNA methylation in normal and transformed human cells. Nat Genet (2005) 15.37
Pyrosequencing sheds light on DNA sequencing. Genome Res (2001) 11.87
Cloning the differences between two complex genomes. Science (1993) 10.60
Biology of progressive, castration-resistant prostate cancer: directed therapies targeting the androgen-receptor signaling axis. J Clin Oncol (2005) 10.48
E2F integrates cell cycle progression with DNA repair, replication, and G(2)/M checkpoints. Genes Dev (2002) 10.06
Epigenetic transgenerational actions of endocrine disruptors and male fertility. Science (2005) 10.02
COBRA: a sensitive and quantitative DNA methylation assay. Nucleic Acids Res (1997) 9.94
MethyLight: a high-throughput assay to measure DNA methylation. Nucleic Acids Res (2000) 9.30
Transposable elements: targets for early nutritional effects on epigenetic gene regulation. Mol Cell Biol (2003) 9.30
Glucose tolerance in adults after prenatal exposure to famine. Lancet (1998) 8.87
Quantitative high-throughput analysis of DNA methylation patterns by base-specific cleavage and mass spectrometry. Proc Natl Acad Sci U S A (2005) 8.10
Number of CpG islands and genes in human and mouse. Proc Natl Acad Sci U S A (1993) 6.79
Isolating human transcription factor targets by coupling chromatin immunoprecipitation and CpG island microarray analysis. Genes Dev (2002) 6.74
Temporal and regional changes in DNA methylation in the embryonic, extraembryonic and germ cell lineages during mouse embryo development. Development (1987) 6.16
Developmental exposure to estradiol and bisphenol A increases susceptibility to prostate carcinogenesis and epigenetically regulates phosphodiesterase type 4 variant 4. Cancer Res (2006) 5.92
Computational identification of promoters and first exons in the human genome. Nat Genet (2001) 5.88
Matrix-assisted laser desorption/ionization mass spectrometry of biopolymers. Anal Chem (1991) 5.62
A genomic screen for genes upregulated by demethylation and histone deacetylase inhibition in human colorectal cancer. Nat Genet (2002) 5.38
Precision and performance characteristics of bisulfite conversion and real-time PCR (MethyLight) for quantitative DNA methylation analysis. J Mol Diagn (2006) 4.68
Maternal genistein alters coat color and protects Avy mouse offspring from obesity by modifying the fetal epigenome. Environ Health Perspect (2006) 4.46
Purification of CpG islands using a methylated DNA binding column. Nat Genet (1994) 4.31
The relation of small head circumference and thinness at birth to death from cardiovascular disease in adult life. BMJ (1993) 4.26
Developmental pattern of gene-specific DNA methylation in the mouse embryo and germ line. Genes Dev (1992) 4.02
Direct detection of methylated cytosine in DNA by use of the restriction enzyme MspI. Nucleic Acids Res (1979) 3.99
High-throughput screening of chromatin immunoprecipitates using CpG-island microarrays. Methods Enzymol (2004) 3.76
S-Adenosylmethionine and methylation. FASEB J (1996) 3.48
Identification of differentially methylated sequences in colorectal cancer by methylated CpG island amplification. Cancer Res (1999) 3.48
Gene expression profiling of multiple histone deacetylase (HDAC) inhibitors: defining a common gene set produced by HDAC inhibition in T24 and MDA carcinoma cell lines. Mol Cancer Ther (2003) 3.37
Metastable epialleles in mammals. Trends Genet (2002) 3.36
Methylation profiling of CpG islands in human breast cancer cells. Hum Mol Genet (1999) 3.26
Methylation matters. J Med Genet (2001) 3.00
Endocrine disruptor vinclozolin induced epigenetic transgenerational adult-onset disease. Endocrinology (2006) 2.85
Epigenetics and human disease. Annu Rev Genomics Hum Genet (2004) 2.78
Specific method for the determination of genomic DNA methylation by liquid chromatography-electrospray ionization tandem mass spectrometry. Anal Chem (2005) 2.78
DNA methylation: a profile of methods and applications. Biotechniques (2002) 2.74
Methylation-specific oligonucleotide microarray: a new potential for high-throughput methylation analysis. Genome Res (2002) 2.71
The developmental origins of the metabolic syndrome. Trends Endocrinol Metab (2004) 2.55
CpG-island methylation in aging and cancer. Curr Top Microbiol Immunol (2000) 2.54
Epigenetic gene regulation: linking early developmental environment to adult disease. Reprod Toxicol (2006) 2.49
LUMA (LUminometric Methylation Assay)--a high throughput method to the analysis of genomic DNA methylation. Exp Cell Res (2006) 2.48
Analysis of Myc bound loci identified by CpG island arrays shows that Max is essential for Myc-dependent repression. Curr Biol (2003) 2.47
DNA methyltransferase inhibitors and the development of epigenetic cancer therapies. J Natl Cancer Inst (2005) 2.43
Tissue-specific differences in DNA methylation in various mammals. Biochim Biophys Acta (1983) 2.40
Adverse effects of the model environmental estrogen diethylstilbestrol are transmitted to subsequent generations. Endocrinology (2006) 2.35
Aberrant DNA methylation as a cancer-inducing mechanism. Annu Rev Pharmacol Toxicol (2005) 2.34
Genome-wide profiling of CpG methylation identifies novel targets of aberrant hypermethylation in myeloid leukemia. Cancer Res (2006) 2.22
DNA methylation. Blood (1999) 2.10
A genomic scanning method for higher organisms using restriction sites as landmarks. Proc Natl Acad Sci U S A (1991) 2.08
Locus-specific mutation databases: pitfalls and good practice based on the p53 experience. Nat Rev Cancer (2006) 2.05
Epigenetics and human disease: translating basic biology into clinical applications. CMAJ (2006) 1.98
CpG Island microarray probe sequences derived from a physical library are representative of CpG Islands annotated on the human genome. Nucleic Acids Res (2005) 1.89
Sequencing exons 5 to 8 of the p53 gene by MALDI-TOF mass spectrometry. Nat Biotechnol (1998) 1.87
Promoter methylation of P16, RARbeta, E-cadherin, cyclin A1 and cytoglobin in oral cancer: quantitative evaluation using pyrosequencing. Br J Cancer (2006) 1.84
Epigenetic profiling of cutaneous T-cell lymphoma: promoter hypermethylation of multiple tumor suppressor genes including BCL7a, PTPRG, and p73. J Clin Oncol (2005) 1.78
Mechanisms by which poor early growth programs type-2 diabetes, obesity and the metabolic syndrome. Physiol Behav (2006) 1.74
Developmental exposure to diethylstilbestrol elicits demethylation of estrogen-responsive lactoferrin gene in mouse uterus. Cancer Res (1997) 1.74
CpG island arrays: an application toward deciphering epigenetic signatures of breast cancer. Clin Cancer Res (2000) 1.73
Epigenetic reprogramming during early development in mammals. Reproduction (2004) 1.72
Suppression of the protein tyrosine phosphatase receptor type O gene (PTPRO) by methylation in hepatocellular carcinomas. Oncogene (2003) 1.64
Birthweight, vitamin D receptor genotype and the programming of osteoporosis. Paediatr Perinat Epidemiol (2001) 1.61
Genistein alters methylation patterns in mice. J Nutr (2002) 1.60
Epigenetic silencing of the PTEN gene in melanoma. Cancer Res (2006) 1.58
Dynamic regulation of estrogen receptor-beta expression by DNA methylation during prostate cancer development and metastasis. Am J Pathol (2004) 1.52
Birth weight and the risk of depressive disorder in late life. Br J Psychiatry (2001) 1.52
Analysis and accurate quantification of CpG methylation by MALDI mass spectrometry. Nucleic Acids Res (2003) 1.46
siRNA-mediated transcriptional gene silencing: the potential mechanism and a possible role in the histone code. Cell Mol Life Sci (2005) 1.46
Differential distribution of DNA methylation within the RASSF1A CpG island in breast cancer. Cancer Res (2003) 1.45
Methylation-specific PCR unraveled. Cell Oncol (2004) 1.44
Epigenetic regulation by histone methylation and histone variants. Mol Endocrinol (2005) 1.42
Epigenomics: mapping the methylome. Cell Cycle (2006) 1.42
Triple analysis of the cancer epigenome: an integrated microarray system for assessing gene expression, DNA methylation, and histone acetylation. Cancer Res (2003) 1.38
Identification of DNA methylation markers for human breast carcinomas using the methylation-sensitive restriction fingerprinting technique. Cancer Res (1997) 1.37
The future of DNA sequencing. Science (1993) 1.37
A novel procedure for efficient genotyping of single nucleotide polymorphisms. Nucleic Acids Res (2000) 1.35
Serial pyrosequencing for quantitative DNA methylation analysis. Biotechniques (2006) 1.34
Neonatal diethylstilbestrol exposure induces persistent elevation of c-fos expression and hypomethylation in its exon-4 in mouse uterus. Mol Carcinog (2003) 1.30
Evidence for monozygotic twin (MZ) discordance in methylation level at two CpG sites in the promoter region of the catechol-O-methyltransferase (COMT) gene. Am J Med Genet B Neuropsychiatr Genet (2006) 1.26
Insights into the genetic basis of congenital heart disease. Cell Mol Life Sci (2006) 1.25
Identification and characterization of differentially methylated CpG islands in pancreatic carcinoma. Cancer Res (2001) 1.22
Measurement of genome wide DNA methylation by reversed-phase high-performance liquid chromatography. Methods (2002) 1.22
Epigenetics of gene expression in human hepatoma cells: expression profiling the response to inhibition of DNA methylation and histone deacetylation. BMC Genomics (2006) 1.20
Methylation of CpG islands of p16 associated with progression of primary gastric carcinomas. Lab Invest (2006) 1.15
Methylation of p16 CpG islands associated with malignant transformation of gastric dysplasia in a population-based study. Clin Cancer Res (2004) 1.14
DNA methylation is required for silencing of ant4, an adenine nucleotide translocase selectively expressed in mouse embryonic stem cells and germ cells. Stem Cells (2005) 1.14
Overview on the application of transcription profiling using selected nephrotoxicants for toxicology assessment. Environ Health Perspect (2004) 1.14
Identification of genes up-regulated by histone deacetylase inhibition with cDNA microarray and exploration of epigenetic alterations on hepatoma cells. J Hepatol (2004) 1.13
Rapid analysis of CpG methylation patterns using RNase T1 cleavage and MALDI-TOF. Nucleic Acids Res (2004) 1.10
Global methylation screening in the Arabidopsis thaliana and Mus musculus genome: applications of virtual image restriction landmark genomic scanning (Vi-RLGS). Nucleic Acids Res (2003) 1.10
Quantitative analysis of SNRPN(correction of SRNPN) gene methylation by pyrosequencing as a diagnostic test for Prader-Willi syndrome and Angelman syndrome. Clin Chem (2006) 1.09
The history of DES, lessons to be learned. Pharm World Sci (2005) 1.06
Removal of repetitive sequences from FISH probes using PCR-assisted affinity chromatography. Hum Genet (1997) 1.05
Gene expression profiling of choline-deprived neural precursor cells isolated from mouse brain. Brain Res Mol Brain Res (2004) 1.04
Restriction landmark genomic scanning (RLGS-M)-based genome-wide scanning of mouse liver tumors for alterations in DNA methylation status. Cancer Res (1997) 1.04
Effect of long-term tamoxifen exposure on genotoxic and epigenetic changes in rat liver: implications for tamoxifen-induced hepatocarcinogenesis. Carcinogenesis (2006) 1.03
DNA methylation and ovarian cancer. I. Analysis of CpG island hypermethylation in human ovarian cancer using differential methylation hybridization. Gynecol Oncol (2001) 1.03
Frequent genetic and epigenetic abnormalities contribute to the deregulation of cytoglobin in non-small cell lung cancer. Hum Mol Genet (2006) 1.01
Relation of DNA methylation of 5'-CpG island of ACSL3 to transplacental exposure to airborne polycyclic aromatic hydrocarbons and childhood asthma. PLoS One (2009) 2.38
Epigenetic alterations by DNA methylation in house dust mite-induced airway hyperresponsiveness. Am J Respir Cell Mol Biol (2013) 0.86